The heterogenous landscape of EGFR Del19 mutation subtype: not all are the same for osimertinib

Transl Lung Cancer Res. 2024 Apr 29;13(4):952-955. doi: 10.21037/tlcr-24-30. Epub 2024 Apr 24.

Authors

Boris Duchemann^{1

2}, Emmanuelle Fabre³, Jordi Remon⁴

Affiliations

¹ Medical and Thoracic Oncology, HUPSSD Avicenne Hospital APHP, Bobigny, France.
² INSERM UMR1272, Paris 13, the University Sorbonne Paris Nord, Bobigny, France.
³ Biochemistry Department AP-HP, HUPSSD Avicenne Hospital APHP, Bobigny, France.
⁴ Department of Cancer Medicine, Paris-Saclay University, Gustave Roussy, Villejuif, France.

No abstract available

Publication types

Editorial
Comment